Back
ProShares UltraShort Real Estate Vs. Astrana Health Industry Stock Comparison
Sell
32
SRS
ProShares UltraShort Real Estate
Last Price:
47.11
Seasonality Move:
-10.56%
Sell
11
ASTH
Astrana Health
Last Price:
41.9300
Seasonality Move:
25.02%
Sell
32
ProShares UltraShort Real Estate (SRS)
is a Sell
Is ProShares UltraShort Real Estate a Buy, Sell or Hold?
- The current ProShares UltraShort Real Estate [SRS] share price is $48.10. The Score for SRS is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- SRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
- The current Astrana Health [ASTH] share price is $42.9300. The Score for ASTH is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- ASTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SRS Stock Price Chart
What is ProShares UltraShort Real Estate's stock price today?
-
The ProShares UltraShort Real Estate share price today is $48.10
The current trend is relatively stagnant and SRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $42.9300
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing selling pressure, which indicates risk of future bearish movement.
SRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 55.3 | Buy |
| Chaikin Money Flow: | 16813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.2 - 47.72) | Buy |
| Bollinger Bands (100): | (44.82 - 55.5) | Sell |
ASTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.01 | Sell |
| Relative Strength Index (14 RSI): | 27.01 | Sell |
| Chaikin Money Flow: | -465704 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.464 - 60.504) | Sell |
| Bollinger Bands (100): | (44.6431 - 56.9831) | Sell |
SRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.51 | Buy |
| 20-day SMA: | 46.38 | Buy |
| 50-day SMA: | 46.01 | Buy |
| 200-day SMA: | 56.72 | Sell |
| 8-day EMA: | 47.25 | Buy |
| 20-day EMA: | 46.8 | Buy |
| 50-day EMA: | 47.32 | Buy |
| 200-day EMA: | 55.17 | Sell |
ASTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.51 | Sell |
| 20-day SMA: | 55.48 | Sell |
| 50-day SMA: | 55.12 | Sell |
| 200-day SMA: | 45.28 | Sell |
| 8-day EMA: | 50.74 | Sell |
| 20-day EMA: | 53.85 | Sell |
| 50-day EMA: | 53.99 | Sell |
| 200-day EMA: | 46.89 | Sell |
ProShares UltraShort Real Estate Earnings Growth & SRS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astrana Health Earnings Growth & ASTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.13 per share.
ProShares UltraShort Real Estate Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Astrana Health Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||